Grgurević M
Jugosl Ginekol Opstet. 1977;17(5-6):351-63.
Chemotherapy is routinely applied in a number of malign tumours of female genital organs, primarily in the tumours of the trophoblast and ovarian carcinoma. Its use is often in discord with the present-day konwledge, either in the choice of cytostatics and the optimal time of application or in the combination of different drugs and their dosage. A brief review is given of the basic aspects of cellular biology, of the characteristics of normal and tumour cells, and the principles underlying present-day chemotherapy. Cytostatics having proved particularly effective in the treatment of gynecological tumours are listed separately, along with their daily and total doses and the toxic effects they produce. Also the most frequent schemes for polychemotherapy are presented. Except for the treatment of choriocarcinoma, chemotherapy in gynecology is still the auxiliary method, and for this reason it should be rendered accordant with the classical treatment by radiation and surgery. Chemotherapy is developing very rapidly and what at present is considered peripheral may become of prime importance tomorrow. An all-round plan in the therapy of genital carcinoma can be established only in institutions in which teams of related experts monitor all advances in this field.
化疗通常应用于多种女性生殖器官恶性肿瘤,主要用于滋养层肿瘤和卵巢癌。其使用往往与当前的知识不一致,无论是在细胞抑制剂的选择、最佳应用时间方面,还是在不同药物的联合使用及其剂量方面。本文简要回顾了细胞生物学的基本方面、正常细胞和肿瘤细胞的特征,以及当今化疗的基本原理。分别列出了已证明对妇科肿瘤治疗特别有效的细胞抑制剂,以及它们的每日剂量和总剂量及其产生的毒性作用。还介绍了最常用的联合化疗方案。除了绒毛膜癌的治疗外,妇科化疗仍然是辅助方法,因此,它应与传统的放疗和手术治疗相一致。化疗发展非常迅速,目前被认为是次要的内容明天可能会变得至关重要。只有在相关专家团队监测该领域所有进展的机构中,才能制定出生殖器癌治疗的全面计划。